内分泌学
内科学
低密度脂蛋白受体
罗格列酮
吡格列酮
噻唑烷二酮
胰岛素抵抗
受体
兴奋剂
PPAR激动剂
脂肪组织
过氧化物酶体增殖物激活受体
化学
脂蛋白
生物
糖尿病
医学
胆固醇
2型糖尿病
作者
Jacqueline C. Silva,Fernanda Andrade de César,Edson Mendes de Oliveira,Walter Miguel Turato,Gustavo Luis Tripodi,Gabriela Castilho,Adriana Machado‐Lima,Beatriz de las Heras,Lisardo Boscá,Marcelo Montenegro Rabello,Marcelo Zaldini Hernandes,Marina Galdino da Rocha Pitta,Ivan da Rocha Pitta,Marisa Passarelli,Martina Rudnicki,Dulcinéia Saes Parra Abdalla
标识
DOI:10.1016/j.phrs.2015.12.010
摘要
Peroxisome proliferator-activated receptor gamma (PPARγ) regulates multiple pathways involved in the pathogenesis of obesity and atherosclerosis. Here, we evaluated the therapeutic potential of GQ-177, a new thiazolidinedione, on diet-induced obesity and atherosclerosis. The intermolecular interaction between PPARγ and GQ-177 was examined by virtual docking and PPAR activation was determined by reporter gene assay identifying GQ-177 as a partial and selective PPARγ agonist. For the evaluation of biological activity of GQ-177, low-density lipoprotein receptor-deficient (LDLr(-/-)) C57/BL6 mice were fed either a high fat diabetogenic diet (diet-induced obesity), or a high fat atherogenic diet, and treated with vehicle, GQ-177 (20mg/kg/day), pioglitazone (20mg/kg/day, diet-induced obesity model) or rosiglitazone (15mg/kg/day, atherosclerosis model) for 28 days. In diet-induced obesity mice, GQ-177 improved insulin sensitivity and lipid profile, increased plasma adiponectin and GLUT4 mRNA in adipose tissue, without affecting body weight, food consumption, fat accumulation and bone density. Moreover, GQ-177 enhanced hepatic mRNA levels of proteins involved in lipid metabolism. In the atherosclerosis mice, GQ-177 inhibited atherosclerotic lesion progression, increased plasma HDL and mRNA levels of PPARγ and ATP-binding cassette A1 in atherosclerotic lesions. GQ-177 acts as a partial PPARγ agonist that improves obesity-associated insulin resistance and dyslipidemia with atheroprotective effects in LDLr(-/-) mice.
科研通智能强力驱动
Strongly Powered by AbleSci AI